Your browser doesn't support javascript.
loading
Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela, Mitchell J; Hofmann, Jonathan N; Carreras-Torres, Robert; Brown, Kevin M; Johansson, Mattias; Wang, Zhaoming; Foll, Matthieu; Li, Peng; Rothman, Nathaniel; Savage, Sharon A; Gaborieau, Valerie; McKay, James D; Ye, Yuanqing; Henrion, Marc; Bruinsma, Fiona; Jordan, Susan; Severi, Gianluca; Hveem, Kristian; Vatten, Lars J; Fletcher, Tony; Koppova, Kvetoslava; Larsson, Susanna C; Wolk, Alicja; Banks, Rosamonde E; Selby, Peter J; Easton, Douglas F; Pharoah, Paul; Andreotti, Gabriella; Freeman, Laura E Beane; Koutros, Stella; Albanes, Demetrius; Mannisto, Satu; Weinstein, Stephanie; Clark, Peter E; Edwards, Todd E; Lipworth, Loren; Gapstur, Susan M; Stevens, Victoria L; Carol, Hallie; Freedman, Matthew L; Pomerantz, Mark M; Cho, Eunyoung; Kraft, Peter; Preston, Mark A; Wilson, Kathryn M; Gaziano, J Michael; Sesso, Howard S; Black, Amanda; Freedman, Neal D; Huang, Wen-Yi.
Afiliação
  • Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Carreras-Torres R; International Agency for Research on Cancer (IARC), Lyon, France.
  • Brown KM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Johansson M; International Agency for Research on Cancer (IARC), Lyon, France.
  • Wang Z; St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Foll M; International Agency for Research on Cancer (IARC), Lyon, France.
  • Li P; International Agency for Research on Cancer (IARC), Lyon, France.
  • Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Savage SA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Gaborieau V; International Agency for Research on Cancer (IARC), Lyon, France.
  • McKay JD; International Agency for Research on Cancer (IARC), Lyon, France.
  • Ye Y; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Henrion M; Icahn School of Medicine, New York, NY, USA.
  • Bruinsma F; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia.
  • Jordan S; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; School of Public Health, The University of Queensland, Brisbane, Australia.
  • Severi G; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Australia; Human Genetics Foundation (HuGeF), Torino, Italy; Centre de Rech
  • Hveem K; HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Levanger, Sweden.
  • Vatten LJ; Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Fletcher T; London School of Hygiene and Tropical Medicine, University of London, London, UK.
  • Koppova K; Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia.
  • Larsson SC; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Banks RE; Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK.
  • Selby PJ; Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital, Leeds, UK.
  • Easton DF; Department of Oncology, and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Pharoah P; Department of Oncology, and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Andreotti G; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Freeman LEB; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Koutros S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Albanes D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Mannisto S; National Institute for Health and Welfare, Helsinki, Finland.
  • Weinstein S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Clark PE; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Edwards TE; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Lipworth L; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Gapstur SM; American Cancer Society, Atlanta, GA, USA.
  • Stevens VL; American Cancer Society, Atlanta, GA, USA.
  • Carol H; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Freedman ML; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Pomerantz MM; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cho E; Brown University, Providence, RI, USA.
  • Kraft P; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Preston MA; Brigham and Women's Hospital, Boston, MA, USA.
  • Wilson KM; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Gaziano JM; Brigham and Women's Hospital, Boston, MA, USA; Veterans Administration, Boston, MA, USA.
  • Sesso HS; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Black A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
  • Huang WY; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, MS, USA.
Eur Urol ; 72(5): 747-754, 2017 11.
Article em En | MEDLINE | ID: mdl-28797570
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Telômero / Polimorfismo de Nucleotídeo Único / Homeostase do Telômero / Neoplasias Renais Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Telômero / Polimorfismo de Nucleotídeo Único / Homeostase do Telômero / Neoplasias Renais Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article